Get it on Google Play

Janssen (JNJ) Receives FDA Priority View for sNDA of ZYTIGA

August 29, 2012 8:19 AM EDT Send to a Friend
Janssen Research & Development, LLC, announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login